AIT’s Inhaled Nitric Oxide Shows Potential in Fighting Bacterial Infection Prevalent in CF Patients
Inhaled nitric oxide (NO) was shown to be an effective antibacterial agent against Mycobacterium abscessus infection in preclinical...
Cystic Fibrosis: Antioxidant-Enriched MVI May Decrease Respiratory Illnesses
MedicalResearch.com Interview with: Scott D Sagel MD PhD Professor of Pediatrics University of Colorado School of Medicine Aurora,...
New Method to Deliver Bacteria-killing Viruses Seen to Resolve Lung Infections in CF Mice
A new therapy which is administered directly into the lung of viruses can kill bacteria, and was shown to be effective in reducing...
Harmful Bacteria Replace Beneficial Ones in Gut of CF Patients, Study Finds
Cystic fibrosis (CF) patients have a higher amount of harmful gut bacteria and increased levels of intestinal inflammation than healthy...
P. aeruginosa Infection Differs Between Cystic Fibrosis and Non-CF Bronchiectasis, Study Shows
Pseudomonas aeruginosa, one of the most common types of bacteria present in severe lung infections, infects cystic fibrosis (CF) patients...
Triclosan, often maligned, may have a good side — treating cystic fibrosis infections
Maybe you’ve had the experience of wading in a stream and struggling to keep your balance on the slick rocks, or forgetting to brush your...
Vertex, NHS England no closer to Orkambi settlement
Vertex and NHS England remain locked in a battle over the provision of cystic fibrosis drug Orkambi, seemingly no closer to a settlement...
Proof that Mycobacterium Abscessus Doesn’t Always Lead to Transplant Failure
Part two of a series. Read part one. Last week, I wrote about how disheartened I felt that many lung transplant centers refuse to help...
Azithromycin Reduced Pulmonary Exacerbation Risk in Cystic Fibrosis
Azithromycin significantly reduced the risk for pulmonary exacerbations and resulted in sustained improvement in weight but had no effect...
Health Canada Approves Symdeko to Treat CF Patients 12 and Up with Certain Gene Mutations
People ages 12 and older with cystic fibrosis (CF) who live in Canada can now be treated with Vertex Pharmaceuticals’ Symdeko...
